Viewing Study NCT02156245



Ignite Creation Date: 2024-05-06 @ 2:55 AM
Last Modification Date: 2024-10-26 @ 11:25 AM
Study NCT ID: NCT02156245
Status: COMPLETED
Last Update Posted: 2019-07-22
First Post: 2014-03-05

Brief Title: Evaluation of the Effects of Eccentric Training on a Cycle Ergometer Versus Conventional Concentric Training
Sponsor: Centre Hospitalier Universitaire Dijon
Organization: Centre Hospitalier Universitaire Dijon

Study Overview

Official Title: Evaluation of the Effects of Eccentric Training on a Cycle Ergometer Versus Conventional Concentric Training
Status: COMPLETED
Status Verified Date: 2019-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: ENERGETIC
Brief Summary: The aim of this study is to assess the efficacy of a rehabilitation protocol based on individualized combined eccentric and concentric cycle ergometer training compared to classical concentric cycle training among patients with either coronary artery disease CAD or chronic obstructive pulmonary disease COPD This study will therefore evaluate the efficacy of combined eccentricconcentric training on physical capacity and overall autonomy and will analyse the adaptive mechanisms with regard to both adaptation to cardiac and muscular effort and tolerance
Detailed Description: The research will take place in 3 phases

PHASE 1

30 healthy volunteers will be included to test tolerance to personalized exercise on an eccentric cycle ergometer

PHASE 2

15 patients suffering from coronary artery disease CAD and 15 patients suffering from chronic obstructive pulmonary disease COPD will be included to test the same protocol

PHASE 3

A total of 169 patients split into 2 parallel groups will be included a group receiving conventional rehabilitation group A and the other group receiving eccentric exercise combined to conventional rehabilitation group B

Coronary patients 93 patients will be included 62 patients in group A and 31 in group B

COPD patients 76 patients will be included 38 patients per group

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None